CV Sciences Inc (CVSI)
0.0556
+0.01
(+11.08%)
USD |
OTCM |
May 20, 15:58
CV Sciences Enterprise Value: 7.098M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.098M |
| May 16, 2024 | 7.115M |
| May 15, 2024 | 7.082M |
| May 14, 2024 | 7.588M |
| May 13, 2024 | 7.572M |
| May 10, 2024 | 7.098M |
| May 09, 2024 | 7.000M |
| May 08, 2024 | 6.935M |
| May 07, 2024 | 7.670M |
| May 06, 2024 | 6.769M |
| May 03, 2024 | 6.119M |
| May 02, 2024 | 5.246M |
| May 01, 2024 | 5.988M |
| April 30, 2024 | 6.870M |
| April 29, 2024 | 5.368M |
| April 26, 2024 | 5.083M |
| April 25, 2024 | 5.417M |
| April 24, 2024 | 5.417M |
| April 23, 2024 | 5.132M |
| April 22, 2024 | 5.132M |
| April 19, 2024 | 5.434M |
| April 18, 2024 | 4.947M |
| April 17, 2024 | 5.246M |
| April 16, 2024 | 5.140M |
| April 15, 2024 | 5.019M |
| Date | Value |
|---|---|
| April 12, 2024 | 5.140M |
| April 11, 2024 | 4.568M |
| April 10, 2024 | 5.221M |
| April 09, 2024 | 5.180M |
| April 08, 2024 | 5.140M |
| April 05, 2024 | 5.638M |
| April 04, 2024 | 5.737M |
| April 03, 2024 | 5.466M |
| April 02, 2024 | 5.215M |
| April 01, 2024 | 5.140M |
| March 28, 2024 | 5.629M |
| March 27, 2024 | 5.303M |
| March 26, 2024 | 5.303M |
| March 25, 2024 | 5.303M |
| March 22, 2024 | 4.757M |
| March 21, 2024 | 4.260M |
| March 20, 2024 | 4.668M |
| March 19, 2024 | 4.780M |
| March 18, 2024 | 4.618M |
| March 15, 2024 | 4.369M |
| March 14, 2024 | 4.491M |
| March 13, 2024 | 4.441M |
| March 12, 2024 | 3.917M |
| March 11, 2024 | 4.027M |
| March 08, 2024 | 4.285M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.840M
Minimum
Nov 16 2023
470.05M
Maximum
May 24 2019
55.72M
Average
21.06M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 817.27M |
| Electromed Inc | 130.07M |
| Xtant Medical Holdings Inc | 116.32M |
| Asensus Surgical Inc | 62.82M |
| Myomo Inc | 93.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.869M |
| Revenue (Quarterly) | 3.801M |
| Total Expenses (Quarterly) | 4.69M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 45.83% |
| Profit Margin (Quarterly) | -22.86% |
| Earnings Yield | 30.74% |
| Operating Earnings Yield | 39.22% |
| Normalized Earnings Yield | 30.74 |